Rosalind Advisors, Inc. 13F Portfolio

EntityCategoryQoQ AUM ChangeAUM (13F)# of HoldingsPerformance RankEquities Trend
RA
Rosalind Advisors, Inc.
Institutional Filer 11.07%$244.1M32

Current Portfolio Holdings

Showing all 32 reported positions by value

#StockCompany NameSectorShares HeldMarket Value% of Portfolio
1DCTHDelcath Systems, Inc.Healthcare3.3M$30.6M12.55%
2XERSXeris Biopharma Holdings, Inc.Healthcare3.2M$18.7M7.68%
3FENCFennec Pharmaceuticals Inc.Healthcare2.9M$17.9M7.33%
4SVRASavara Inc.Healthcare3.2M$17.5M7.17%
5PCVXVaxcyte, Inc.Healthcare290K$16.9M6.90%
6EYPTEyePoint Pharmaceuticals, Inc.Healthcare1.0M$13.4M5.48%
7XFORX4 Pharmaceuticals, Inc.Healthcare3.2M$13.3M5.44%
8VORVor Biopharma Inc.Healthcare700K$12.5M5.12%
9MDWDMediWound Ltd.Healthcare749K$12.1M4.94%
10VSTMVerastem, Inc.Healthcare2.1M$11.3M4.64%
11CLDXCelldex Therapeutics, Inc.Healthcare330K$10.5M4.29%
12BCRXBioCryst Pharmaceuticals, Inc.Healthcare923K$8.8M3.60%
13HELPCYBIN INC1.5M$7.4M3.01%
14CGONCG Oncology, Inc. Common stockHealthcare100K$6.8M2.77%
15NSPRInspireMD, Inc.Healthcare3.9M$6.4M2.61%
Showing 1 to 15 of 32 holdings